<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399854</url>
  </required_header>
  <id_info>
    <org_study_id>02CBED0501</org_study_id>
    <nct_id>NCT00399854</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring</brief_title>
  <official_title>Clinical Study for Evaluation of the Efficacy of Mechanical Massage by Endermologie (Dhermia® - Industra Mecânica Fina Ltda) in Treatment of Cellulite and Body Contouring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brazilan Center for Studies in Dermatology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brazilan Center for Studies in Dermatology</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform a clinical assessment of the efficacy of the device&#xD;
      DHERMIA® (Industra Mecânica Fina Ltda)in the treatment of cellulite and body contouring&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study is a clinical, opened trial and single-center.&#xD;
&#xD;
      The patients were treated by endermologie device. Mechanical massage were performed for 12&#xD;
      weeks in a total of 24 treatment sessions: twice a week.&#xD;
&#xD;
      A set of photographs were took at visit 1 (baseline), visit 2, 3 and 4 with standardized&#xD;
      positions and lighting conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date>July 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of effectiveness of treatment based on current classification of cellulite and evaluation of the corporal measures</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of subject's satisfaction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual assessments of the treated area before and after treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety analysis</measure>
  </secondary_outcome>
  <enrollment>45</enrollment>
  <condition>Cellulite</condition>
  <condition>Body Contouring</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dhermia® - Industra Mecânica Fina Ltda</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Written Informed Consent;&#xD;
&#xD;
          2. Subjects agreeing to take part of all procedures of the study (including mechanical&#xD;
             massage, photographs), after being fully informed on the objectives and nature of the&#xD;
             investigations;&#xD;
&#xD;
          3. Female subjects between 25-45 years;&#xD;
&#xD;
          4. Subjects presenting with cellulite grades I-III on buttocks and thighs;&#xD;
&#xD;
          5. Medical history and physical examination which, based on the investigator's opinion,&#xD;
             do not prevent the patient from taking part in the study and use the device under&#xD;
             investigation;&#xD;
&#xD;
          6. Female subjects of childbearing age should present a negative urine pregnancy test and&#xD;
             should be using an effective contraceptive method (3 months before the enrollement&#xD;
             untill the end of the study);&#xD;
&#xD;
          7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0 and 25,0-29,9;&#xD;
&#xD;
          8. Availability of the subject throughout the duration of the study (90 days);&#xD;
&#xD;
          9. Availability of the subject in maintaining a stable weight during the study (variation&#xD;
             less than 2 kg)&#xD;
&#xD;
         10. Subjects with sufficient schooling and awareness to enable them to cooperate to the&#xD;
             degree required by this protocol.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant women or women intending to become pregnant during the study (next 3 months);&#xD;
&#xD;
          2. BMI superior 30,0;&#xD;
&#xD;
          3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis;&#xD;
&#xD;
          4. Subjects participating in other clinical trials;&#xD;
&#xD;
          5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled&#xD;
             hypertension;&#xD;
&#xD;
          6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises;&#xD;
&#xD;
          7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be&#xD;
             treated;&#xD;
&#xD;
          8. Any prior aesthetic surgery affecting the area to be treated (liposuction,&#xD;
             Subcision®), 3 months before the study, that may interfere with results;&#xD;
&#xD;
          9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to&#xD;
             the study;&#xD;
&#xD;
         10. Subjects with inflammation or active infection in the area to be treated.&#xD;
&#xD;
         11. Subjects with a history of adverse effects, which in the investigator's opinion should&#xD;
             prevent the patient from participating in the study;&#xD;
&#xD;
         12. Patients with cutaneous or vascular alterations, that difficult visualization and&#xD;
             documentation of cellulite;&#xD;
&#xD;
         13. Subjects with a history of medical treatment non-adherence or showing unwillingness to&#xD;
             adhere to the study protocol;&#xD;
&#xD;
         14. Subjects who can not come to the visits (one missing visit/ month is allowed);&#xD;
&#xD;
         15. Subjects intending to initiate any intensive sport;&#xD;
&#xD;
         16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics,&#xD;
             corticosteroids, or diuretics;&#xD;
&#xD;
         17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or&#xD;
             self-tanning during the study;&#xD;
&#xD;
         18. Any condition that, in the opinion of the investigator, can compromise the evaluation&#xD;
             of the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Doris Hexsel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Brazilan Center for Studies in Dermatology</affiliation>
  </overall_official>
  <verification_date>November 2006</verification_date>
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>November 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2006</study_first_posted>
  <last_update_submitted>November 14, 2006</last_update_submitted>
  <last_update_submitted_qc>November 14, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulite</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

